Cabenuva is a Kit in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is .
| Product ID | 49702-253_0eb2c285-5f70-408e-b710-10888edb2c4e | 
| NDC | 49702-253 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Cabenuva | 
| Generic Name | Cabotegravir And Rilpivirine | 
| Dosage Form | Kit | 
| Marketing Start Date | 2021-01-21 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA212888 | 
| Labeler Name | ViiV Healthcare Company | 
| Active Ingredient Strength | 0 | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2021-01-21 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 49702-240 | Cabenuva | cabotegravir and rilpivirine | 
| 49702-253 | Cabenuva | cabotegravir and rilpivirine | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() CABENUVA  87420884  5335232 Live/Registered  | 
        ViiV Healthcare UK (No.3) Limited  2017-04-21  |